Isabella Quinti Selected Research

Isabella Quinti Research Topics

Disease

16	Common Variable Immunodeficiency 01/2022 - 04/2003
15	Infections 11/2021 - 09/2002
13	Primary Immunodeficiency Diseases 01/2022 - 06/2011
10	COVID-19 04/2022 - 01/2020
6	Bronchiectasis 01/2021 - 02/2005
5	Inflammation (Inflammations) 01/2022 - 07/2016
5	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 09/2002
4	Lung Diseases (Lung Disease) 01/2020 - 05/2007
4	Pneumonia (Pneumonitis) 10/2014 - 02/2005
3	Bruton type agammaglobulinemia 11/2021 - 06/2011
3	Reinfection 01/2021 - 07/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 02/2005
3	Persistent Infection 01/2021 - 07/2008
3	Neoplasms (Cancer) 12/2019 - 01/2014
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018 - 01/2014
2	Sudden Infant Death (SID) 09/2021 - 06/2019
2	Splenomegaly 01/2021 - 07/2016
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2019 - 06/2019
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2019 - 12/2005
2	Immune System Diseases (Immune Disorders) 01/2019 - 12/2005
2	Lymphoma (Lymphomas) 11/2018 - 07/2008
2	Hemolysis 07/2016 - 05/2015
2	Pneumococcal Infections 12/2015 - 04/2003
2	Ataxia (Dyssynergia) 06/2015 - 01/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2015 - 12/2002
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Chronic Urticaria 01/2022
1	Cytopenia 01/2021
1	IgA Deficiency 01/2021
1	Asymptomatic Diseases 01/2021
1	Diarrhea 03/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2019
1	Multiple Myeloma 06/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019
1	Hypersensitivity (Allergy) 11/2018
1	Tachycardia (Tachyarrhythmias) 03/2017
1	Lymphadenopathy 01/2016
1	hypohidrotic Ectodermal dysplasia with immune deficiency 12/2015
1	Anhidrotic Ectodermal Dysplasia 1 12/2015
1	Myasthenia Gravis 01/2014
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2014
1	Thrombocytopenia (Thrombopenia) 01/2014
1	Hemolytic Anemia 01/2014
1	Guillain-Barre Syndrome 01/2014
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2014
1	Human Influenza (Influenza) 05/2013
1	Septic Shock (Toxic Shock Syndrome) 05/2013
1	Rheumatoid Arthritis 05/2013
1	Rheumatic Diseases (Rheumatism) 05/2013
1	Immunologic Deficiency Syndromes 01/2013

Drug/Important Bio-Agent (IBA)

20	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 09/2002
15	Immunoglobulin G (IgG)IBA 01/2022 - 09/2002
10	Immunoglobulin M (IgM)IBA 01/2021 - 04/2003
10	Immunoglobulin A (IgA)IBA 01/2021 - 06/2011
9	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 09/2002
7	AntibodiesIBA 01/2022 - 02/2005
5	VaccinesIBA 11/2021 - 04/2003
5	Polysaccharides (Glycans)IBA 01/2021 - 04/2003
3	Monoclonal AntibodiesIBA 04/2022 - 01/2021
3	BNT162 VaccineIBA 01/2022 - 10/2021
2	Immunoglobulin E (IgE)IBA 01/2022 - 11/2018
2	AutoantibodiesIBA 01/2022 - 09/2009
2	Secretory Immunoglobulin A (SIgA)IBA 01/2021 - 01/2019
2	Inosine Triphosphate (ITP)IBA 03/2017 - 01/2014
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 08/2016 - 09/2015
2	AntigensIBA 12/2015 - 07/2008
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2015 - 01/2014
1	CytokinesIBA 01/2022
1	anti-IgE antibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 09/2021
1	mRNA VaccinesIBA 09/2021
1	InterferonsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Viral AntigensIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	indium oxineIBA 03/2020
1	ibrutinibIBA 12/2019
1	Tyrosine Kinase InhibitorsIBA 12/2019
1	Pancreatic Elastase (Elastase)IBA 01/2019
1	MacrolidesIBA 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	A-factor (Streptomyces)IBA 11/2018
1	IsoantibodiesIBA 07/2016
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 02/2016
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2016
1	LigandsIBA 12/2015
1	NF-kappa B (NF-kB)IBA 12/2015
1	EctodysplasinsIBA 12/2015
1	SteroidsIBA 06/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2014
1	Ethanol (Ethyl Alcohol)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013
1	Etanercept (Enbrel)FDA Link 05/2013

Therapy/Procedure

14	Therapeutics 01/2022 - 05/2007
1	Contraindications 09/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021